AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 73 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $68,000 | +41.7% | 121,754 | 0.0% | 0.00% | – |
Q4 2018 | $48,000 | -61.3% | 121,754 | -50.0% | 0.00% | – |
Q3 2018 | $124,000 | -53.7% | 243,508 | +100.0% | 0.00% | – |
Q2 2018 | $268,000 | +145.9% | 121,754 | -10.5% | 0.00% | – |
Q1 2017 | $109,000 | -15.5% | 136,053 | -5.0% | 0.00% | – |
Q4 2016 | $129,000 | +19.4% | 143,237 | -2.2% | 0.00% | – |
Q3 2016 | $108,000 | -42.9% | 146,417 | 0.0% | 0.00% | – |
Q2 2016 | $189,000 | -25.9% | 146,417 | +36.1% | 0.00% | – |
Q2 2015 | $255,000 | -76.8% | 107,566 | -26.3% | 0.00% | -100.0% |
Q1 2015 | $1,099,000 | +117.6% | 146,015 | -0.8% | 0.00% | – |
Q4 2014 | $505,000 | -5.1% | 147,196 | -2.3% | 0.00% | – |
Q3 2014 | $532,000 | -60.0% | 150,629 | -5.5% | 0.00% | -100.0% |
Q2 2014 | $1,331,000 | +72.0% | 159,438 | +30.8% | 0.00% | 0.0% |
Q1 2014 | $774,000 | -13.4% | 121,939 | -2.7% | 0.00% | 0.0% |
Q4 2013 | $894,000 | +15.7% | 125,379 | +21.7% | 0.00% | 0.0% |
Q3 2013 | $773,000 | +14.7% | 103,019 | -11.8% | 0.00% | 0.0% |
Q2 2013 | $674,000 | – | 116,760 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Shilanski & Associates, Inc. | 937,237 | $57,000 | 0.02% |
PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $57,000 | 0.02% |
CVA Family Office, LLC | 1,137,920 | $69,000 | 0.02% |
Cypress Capital Management LLC (WY) | 140,925 | $9,000 | 0.01% |
Helen Stephens Group, LLC | 117,222 | $7,000 | 0.01% |
COURIER CAPITAL LLC | 540,056 | $33,000 | 0.00% |
NORTHCAPE WEALTH MANAGEMENT, LLC | 98,000 | $6,000 | 0.00% |
Newbridge Financial Services Group, Inc. | 10,000 | $1,000 | 0.00% |
Western Wealth Management, LLC | 352,950 | $11,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 606,800 | $37,000 | 0.00% |